ABSTRACT -The estrogenic activity of industrial chemicals, di(2-ethylhexyl) phthalate (DEHP), di(n-butyl) phthalate (DBP), benzylbutyl phthalate (BBP), diethyl phthalate (DEP), tetrabromobisphenol A (TBBPA), bisphenol A (BPA), and nonylphenol (NP), was compared using OECD test guideline 455(TG455), stably transfected transcriptional activation (STTA) and estrogen receptor (ER) binding assays. The estrogenic activity of BBP, BPA and NP were approximately 180,000-fold (PC 50 , 4.32 x 10 -6 M), 5,000-fold (PC 50 , 1.26 x 10 -7 M) and 120,000-fold (PC 50 , 2.92 x 10 -6 M) less than 17β-estradiol (PC 50 , 2.43 x 10 -11 M), whereas DEHP, DBP and DEP did not show any estrogenicity activity in the STTA assay. Moreover, binding affinities to human ERα of BBP, BPA, and NP were approximately 200,000-fold (IC 50 , 4.91 x 10 -4 M), 8000-fold (IC 50 , 1.92 x 10 -5 M) and 1400-fold (IC 50 , 3.34 x 10 -6 M) less than 17β-estradiol (IC 50 , 2.45 x 10 -9 M) in competitive human ERα binding assay. The relative potencies of STTA assay were very similar to ER binding, E-screen, and Yeast screening assays. Therefore, our results suggested that OECD test guideline TG455 may be useful as a screening test for potential endocrine disruptors.
INTRODUCTION
Endocrine disruptors may be interfered the endocrine system in wildlife and humans reproduction (Colborn et al., 1993; Vos et al., 2000) . They mimic, compete, block alter the activities of endogenous hormones. Previous studies have been reported that endocrine disruptors interrupt interactions of ligand-receptor binding that act as receptor agonist or antagonist (Hunter et al., 1999; Stasinakis et al., 2008) . For rapid alarming health and environmental consequences involved fast and reliable approaches are needed. Based on these results, the Organization for Economic Coorperation and Development (OECD) conceptual framework for testing and assessment of man-made compounds comprised five levels and in vitro screening methods for alternative animal study ranked as level 2 (OECD, 2003) . Recently, the stably transfected transcriptional activation (STTA) assay developed by Japan Chemicals Evaluation and Research Institute (CERI) have been accepted STTA assay as the test guideline 455 (TG 455) in 2009 (OECD, 2009 . The STTA assay is to evaluate the ability of chemicals to function as an estrogen receptor alpha (ERα) ligand and activate an ERα agonistic response. This assay is for screening and prioritization purposes but can also provide mechanistic information. Comparative ER binding assay also generally used to detect ligand-receptor binding (Akahori et al., 2008) and measured the affinity of chemicals to ER receptor protein. There are many assay systems for the detection of environmental estrogenic compounds has been developed. For example, the yeast assay is reporter gene assays that measure ER-dependent transcriptional and translational activity (Coldham et al., 1997) . Furthermore, E-screen assay is MCF-7 cell prolif-eration assay that measure the cell number of target cells during the exponential phase of proliferation (Soto et al., 1995) . Fang et al. (2000) was reported that quantitative comparison study for estrogenic activities with E-screen, reporter gene and ER binding assays. Since adopted STTA assay, there is no scientific report is founded in terms of the relation between ER binding and other in vitro assays. In this study, we compared the relative estrogenic activities on industrial chemicals (di(2-ethylhexyl) phthalate (DEHP), diethyl phthalate (DEP), di(n-butyl) phthalate (DBP), benzylbutyl phthalate (BBP), bisphenol A (BPA), tetrabromobisphenol A (TBBPA) and nonylphenol (NP)) using STTA assay, comparative ER binding assay and E-screen in the literature (Soto et al., 1995) and Yeast assay in the literature (Coldham et al., 1997) . Moreover, we compared the strength of estrogenic activity for test chemicals between STTA and comparative ER binding assay.
MATERIALS AND METHODS

Stably transfected transcriptional activation (STTA) assay
Cell and cell culture medium
The hERα-HeLa-9903 cell line (HeLa9903) which is stably transfected a human ERα gene containing a firefly luciferase gene as a reporter gene was provided from the CERI. The experiments were performed with 5 ~ 28 passages of the cells, which were seeded at 1 x 10 4 cells/ well/100 μl on 96 well plates and incubated cells for 3 hr at 37°C with 5% CO 2 . The reagents of cell culture used commercial products except Dextran-coated charcoal treated fetal bovine serum (DCC-FBS, provided from CERI). The cells were maintained and tested in 10% DCC-FBS-EMEM supplemented with 7.5% NaHCO 3 , 4 mM L-glutamine and 10% DCC-FBS.
Test chemicals
Reference chemicals: 10 mM 17α-estradiol (αE2, Sigma, St. Louis, MO, USA), 10 mM 17β-estradiol (E 2 , Sigma), and 100 mM corticosterone (Wako, Osaka, Japan) were prepared in dimethyl sulfoxide (DMSO) as the stock solution. Test chemicals: benzylbutyl phthalate (BBP, Sigma), di(2-ethylhexyl) phthalate (DEHP, Sigma), di(nbutyl) phthalate (DBP, Sigma) and diethyl phthalate (DEP, Sigma), tetrabromobisphenol A (TBBPA, Sigma), bisphenol A (BPA, Sigma), nonylphenol (Supelco, Bellefonte, PA, USA) were obtained in commercially available. All test chemicals were prepared at log-serial dilutions 10 -5~1 0 -10 M in cell medium from 10 mM stock as final concentration. The test chemicals were prepared in DMSO.
Chemical treatment and determine the luciferase activity
The luciferase activities were determined in accordance with OECD TG 455. Cells were exposed with reference chemicals and serially diluted test chemicals, and then were incubated for 20-24 hr (at 37°C 5% CO 2 ). The media on the cell plates were removed then added 50 μl of luciferase solution (Steady-Glo Luciferase Assay kit, Promega) and the activities were measured by a Luminometer (US Microplate Scintillation and Luminescence Counter, Packard). Each compound has been performed three independent experiments in triplicate. All plates were contained E2 as positive control.
Determine of relative transcriptional activation (RTA)
The fold induction of E 2 (1 nM), at least 4-fold greater than the mean vehicle control (VC), and the values of the *PC 50 (αE 2 , E 2 , corticosterone and test chemicals) were obtained from provided spreadsheet using GraphPad Prism software (GraphPad Software Inc., San Diego, CA, USA). The RTA value of the estrogen activities were obtained from ratios of PC 50 of test chemicals with PC 50 of E2.
*PC 50, The concentratrion of chemical estimated to cause 50% of the response induced by positive control (E 2 at 1 nM) in each plate.
ER binding assay using recombinant human estrogen receptor-α
Recombinant human estrogen receptor alpha protein rhERα, the fused protein, is E 2 binding domain with a glutathione-S-transferase (GST) was provided from CERI.
Test chemicals
Reference chemical: 10 μM 17-β-estradiol (E 2 , Sigma) and 5 nM 17-
Biosciences, NET517) in DMSO were used as the stock solution. Test chemicals: BBP (Sigma), DEHP (Sigma), DBP (Sigma) and DEP (Sigma) were used 10 -2 to 10 -8 M and BPA (Sigma), NP (Supelco) were used 10 -2 to 10 -8 M as final concentration. All test chemicals were prepared in DMSO as solvent.
Competitive Receptor binding assay
The binding assay was followed according to previously reported data (Nakai et al., 1999; Yamasaki et Vol. 37 No. 2 al., 2004 ). An assay buffer, 10 mM of Tris, 1.0 mM of EDTA·2Na·2H 2 O, 1.0 mM of EGTA, 1.0 mM of NaVO 3 , 10% of glycerol, 0.2 mM of leupeptin, 1% BSA and 1.0 mM of DTT at pH 7.4 were mixed freshly on the day of the assay was performed. After addition of 10 μl [ 3 H]-E 2 (final conc. 0.5 nM) and 10 μl test chemicals were mixed with 30 μl hERα (final conc. 0.2 nM) in total volume of 100 μl of assay buffer and set at room temperature for 2 hr. One hundred μl of 0.4% dextran-coated charcoal (DCC) was added into the mixture to removed free [ 3 H]-E 2 and set for 10 min at 4°C then DCC was removed by filtration. Radioactivities of receptor complex of [ 3 H]-E 2 and test chemicals in filtrates, were measured by liquid scintillation counter. Each compound has been performed three independent experiments in triplicate. All plates were contained E2 as positive control.
Determine of relative binding affinity (RBA)
Binding competitions of [ 3 H]-E 2 with test chemicals were analyzed by calculating affinities (B/B0 (%)) using the following equations: Abbreviations; NSB, non-specific binding-dpm of 0.5 nM [ 3 H]-E 2 , 1 μM E 2 and hERα ; TB, total bindingdpm of [ 3 H]-E 2 and hERα ; RBA, the ratio of the molar concentration of E 2 , PC 50 , The concentration of chemical estimated to cause 50% of effective, IC 50 , The concentration of chemical estimated to cause 50% of inhibition. Chemical affinities needed to achieve IC 50 using GraphPad Prism version 4.
RBAs The literature of data sets for comparison should be including alkylphenol and phthalates and individual study have a PC 50 values for in vitro assay, respectively. Four in vitro assays has different units according biological levels. We are presented the relative activity of each assay to compare among assays. In this assays, we used E 2 as an agonistic reference. The absolute concentrations at which E 2 induced half-maximal activities were different for each assay. RBA is the ratio of the molecular concentration of E 2 to that of the competing chemical required to decrease radiolabeled E 2 receptor binding by 50%, which is then multiplied by 100. E 2 has 100 value of RBA, therefore the log RBA value of E 2 is 2. Phthalates and alkylphenols in the data sets have log RBA, RP, PPP and RTA values which were obtained by actual PC 50 of test chemicals against E 2 .
RESULTS AND DISCUSSION
Estrogenic activities of phthalates and alkylphenols
The estrogenic activities of phthalates (DEHP, DBP, BBP, and DEP) and alkylphenols (BPA, NP, and TBB-PA) were determined by STTA assay. The quality control and performance standard were met criteria according to Fig. 1 ). While BBP, BPA and NP had lower activity than E 2 , but DEHP, DBP, DEP and TBBPA were not shown estrogenic activity (Table 2 and Fig. 2) . BBP, BPA and NP were shown weak estrogenic activities which were 180,000-, 5,000-and 120,000-fold lower than E 2 . The rank of order for estrogenic activity has been presented BPA (PC 50 , 1.26E-7) > NP (PC 50 , 2.92E-6) > BBP (PC 50 , 4.32E-6) in STTA assay. For BPA and NP, were reported similar results by Bonefeld-Jørgensen et al. (2007) in MVLN cell line assay which was derived from MCF-7 cell and transfected ERα-ERE coupled luciferase reporter gene. We measured the RBA of phthalates (DEHP, DBP, BBP, and DEP) and alkylphenols (BPA and NP) using the ER binding assay. BBP, BPA and NP showed approximately 200,000-fold, 8,000-fold and 1,400-fold lower than that of E 2 (Table 3 ). In ER binding assay, the rank order of estrogenic activity were exhibited NP (IC 50 , 3.34E-6) > BPA (IC 50 , 1.92E-5) > BBP (IC 50 , 4.91E-4). Previously, a number of studies have been discussed on estrogenic activity of BBP and DBP. BBP has been reported a weak estrogenic activity on MCF-7 cell proliferation test (Picard et al., 2001) . Competitive binding test, BBP was bind to the estrogen receptor in other species of rabbit, rat and trout with other in vitro assays as MCF-7 cell assay, yeast assay, HeLa cell assay, ERbinding assay (Jobling et al., 1995; Zacharewski et al., 1998; Anderson et al., 1999) . Interestingly, Takeuchi et al. (2005) was reported that BBP acts as agonist with hERα and antagonist with hERβ of transcriptional activa- tion test in CHO-K1 cells. DBP also had a weak estrogenic activity but our study showed no estrogenic activity. Out present result is consisting with Zacharewski et al. (1998) . They also reported estrogenic activity of DBP but not in HeLa cell assay. Our results indicated that BPA and NP were have been determined a weak estrogenic activity in this study except TBBPA in STTA assay. Van den Belt et al. (2004) also reported same results by MVLN-assay (based on MCF-7 cells) and YES-screen (based on yeast assay) but it was potential agonist on rat ERα yeast assay. NP has many scientific evidences in in vivo and in vitro studies as agonist. However some publications presented no estrogenic activity on hERα yeast assay (Kolle et al., 2010) . Estrogenic activity of certain chemical such as NP has no consensus on which species and types of ER. Interestingly, these finding was reported in yeast assay mostly (Dang et al., 2011) . Table 4 shows that relative activities of 7 chemicals against E 2 in 4 different assays. Coldham (1997) and Soto's (1995) studies results were used for evaluating relative activities on Yeast and E-screen assays. The relative activities of BPA and NP showed higher in all four assays and BBP showed similar values among assays. The research for NP has been reported, during the isomers had rather higher effect than other chemicals and it has a long side chain on the structure. Routledge and Sumpter (1997) were reported the estrogenic activity of alkyl phenols and they found the relationships between activities and the carbon atoms in the alkyl chain and that branch of the alkyl group. Specifically, BPA showed rather high relative activities in STTA assay in compare with that of Yeast assay. It also suggested that ERα binding would be necessary to have estrogenic activities. Considering the results from STTA assays that showed negative, Miller et al. (2001) was reported similar result to this study by yeast assay. These results suggest that TBBPA may not bind or limitation of bind to ERα. BBP and BPA were well known as ERα bounded weak agonists (Soto et al., 1995; Miller et al., 2001) while DBP was known that it did not bind to recombinant human ERα protein (Seidlová -Wuttke et al., 2005; Kolle et al., 2010) . Additionally, the difference of ranking order for BPA and NP was resulted in the assay principle between transcriptional assay and binding affinity.
Comparison of relative activities of STTA assay against ER binding
In conclusion, STTA assay, since adopted OECD test guideline 455, is useful and corresponds with other in vitro studies based on relative estrogenic activity. Our present results indicate that BPA, NP and BBP act as estrogenic agonist mediated ERα.
